|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenues (Note 12) | |||||
| Cost of revenues | |||||
| Gross profit | |||||
| Research and development expenses | |||||
| General and administrative expenses (Note 11) | |||||
| Operating loss | |||||
| Financing expense | |||||
| Financial income, net | |||||
| Financing income (expenses), net | |||||
| Other loss | |||||
| Net loss | |||||
| Other comprehensive gain (loss) - Foreign currency translation adjustments | |||||
| Comprehensive loss | |||||
| Loss per share (basic) (in Dollars per share) | |||||
| Loss per share (diluted) (in Dollars per share) | |||||
| Basic weighted average number of shares of common stock outstanding (in Shares) | |||||
| Diluted weighted average number of shares of Common Stock outstanding (in Shares) | |||||
Loading...